在EFEMEREYE研究:在EFEMERIS健康数据库中产前药物暴露和眼睛异常发生
Charlotte Dubucs1, Van N'Go2, Anthony Caillet2
1Département d'Anatomie et cytologie pathologiques, IUCT-Oncopole, Toulouse, France; Unité de Pharmaco-épidémiologie, UMR 1027, équipe SPHERE - Study of Perinatal, paediatric and adolescent Health: Epidemiological Research and Evaluation, Université de Toulouse, Toulouse, France.
概括
这项研究发现,法国儿童的产前药物暴露与眼部异常 (OA) 之间存在潜在的联系. 怀孕期间接触与OAs的风险增加有关.
科学领域:
- 眼科医生 眼科 眼科
- 流行病学 流行病学
- 甲状腺学 甲状腺学
背景情况:
- 眼睛异常 (OA) 是儿科健康的一个问题.
- 了解它们的流行率和潜在原因对于早期干预至关重要.
研究的目的:
- 为了确定法国胎儿和儿童中OA的患病率.
- 调查产前药物暴露与OA之间的关联.
主要方法:
- 一项病例控制研究使用了法国高加隆地区的EFEMERIS队列.
- 数据包括OA描述和从出生到2岁的眼科检查结果.
- 分析了2,968个病例和136,619个对照.
主要成果:
- 整体OA患病率为2.13%,先天性眼部形 (COMs) 为0.04%.
- 产前接触影响消化道,心血管和呼吸系统的药物显示出显著的差异.
- 在怀孕期间和怀孕前1个月内,母亲对的暴露增加了OA风险 (OR = 1.24).
结论:
- 这项研究表明,常见的产前药物使用与OA之间可能存在关联.
- 由于COMs的稀有性,建议进行更大的国际研究.
相关概念视频
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K


